• flag
    • flag
    • flag
    • flag
    • flag
    • flag
    • flag
    • flag
  • Have a question? Call us: 
    +1 (800) 472-4508

    Sterigenics International To Triple West Memphis Sterilization Capacity With $15 Million Expansion

    FOR IMMEDIATE RELEASE

     

    DEERFIELD, IL, October 1, 2015 – Sterigenics International LLC, the leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, today announced a $15 million expansion at their West Memphis, Arkansas facility that will triple gamma sterilization capacity.

    Opened in 1999, the West Memphis Sterigenics facility currently offers 2.5 million cubic feet of gamma sterilization capacity. The installation of a new gamma cell will triple capacity to 7.5 million cubic feet and upon completion in early 2017, will result in approximately 20 additional jobs at full capacity.

    “As the demand for medical devices grows globally, our customers can be assured that we will add sterilization capacity to meet their needs,” said Michael Mulhern, CEO of Sterigenics International. “The expansion at West Memphis is just one more example of our ongoing commitment to customers.”

    “Our West Memphis location is experiencing increasing demand for sterilization services,” said Philip Macnabb, President of Sterigenics International LLC. “Given the importance of Memphis as a major U.S. logistics hub, it is a critical piece of our global network that we will continue to build upon and expand in order to best serve customers.”

    About Sterigenics International LLC

    Sterigenics International LLC, along with its affiliates, is a global leader in outsourced contract sterilization services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world. Operating out of 47 facilities in 13 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high-performance materials industries. Through its SteriPro® Labs service, Sterigenics offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and pharmaceuticals and biologics fields. Affiliate Nordion positions Sterigenics as the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Sterigenics International LLC and its affiliates serve more than 2,500 customers around the world and is owned by private equity firms Warburg Pincus and GTCR.

    About Warburg Pincus

    Warburg Pincus LLC is a leading global private equity firm focused on growth investing. The firm has more than $35 billion in assets under management. The firm’s active portfolio of more than 120 companies is highly diversified by stage, sector and geography. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value.

    Founded in 1966, Warburg Pincus has raised 14 private equity funds, which have invested more than $50 billion in over 720 companies in more than 35 countries. The firm is headquartered in New York with offices in Amsterdam, Beijing, Frankfurt, Hong Kong, London, Luxembourg, Mauritius, Mumbai, San Francisco, São Paulo and Shanghai. For more information, please visit www.warburgpincus.com.

    About GTCR

    Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Healthcare and Information Services & Technology industries. The Chicago-based firm pioneered The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $10 billion in over 200 companies. For more information, please visit www.gtcr.com.

    FOR MORE INFORMATION CONTACT:

    John Vita
    John Steven Vita Communications
    847/853-8283
    John.Vita@jsvcom.com